分组1 - Box reported quarterly earnings of $0.31 per share, matching the Zacks Consensus Estimate, but down from $0.45 per share a year ago [1] - The company posted revenues of $301.11 million for the quarter ended October 2025, exceeding the Zacks Consensus Estimate by 0.89% and up from $275.91 million year-over-year [2] - Box has surpassed consensus EPS estimates three times and revenue estimates four times over the last four quarters [2][3] 分组2 - The stock has underperformed, losing about 7.1% since the beginning of the year compared to the S&P 500's gain of 15.8% [3] - The current consensus EPS estimate for the coming quarter is $0.34 on revenues of $303.35 million, and for the current fiscal year, it is $1.28 on revenues of $1.17 billion [7] - The Internet - Software industry, to which Box belongs, is currently in the top 28% of Zacks industries, indicating a favorable outlook compared to the bottom 50% [8]

Company Overview - Teva Pharmaceutical Industries Ltd. is a global pharmaceutical company headquartered in Tel Aviv, Israel, involved in the development, manufacturing, and marketing of both branded and generic drugs, including biosimilars and over-the-counter products, as well as active pharmaceutical ingredients (APIs) [12] - Teva's generic product portfolio includes various forms such as tablets, capsules, liquids, ointments, creams, transdermal patches, injectables, and inhalants [12] - The company plans to separate its API unit into a standalone business unit through a sale [12] Investment Ratings - Teva is currently rated 3 (Hold) on the Zacks Rank, with a VGM Score of B, indicating a solid position in the market [13] - The Value Style Score for Teva is also B, supported by attractive valuation metrics, including a forward P/E ratio of 10.22, which may appeal to value investors [13] Earnings Estimates - In the last 60 days, five analysts have revised their earnings estimates upwards for fiscal 2025, with the Zacks Consensus Estimate increasing by $0.07 to $2.61 per share [13] - Teva has demonstrated an average earnings surprise of +7.9%, indicating a positive trend in earnings performance [13] Investment Consideration - With a solid Zacks Rank and favorable Value and VGM Style Scores, Teva is recommended to be on investors' short lists for potential investment opportunities [14]

Core Viewpoint - OCADO GROUP has been upgraded to a Zacks Rank 2 (Buy), indicating a positive trend in earnings estimates which is a significant factor influencing stock prices [1][3]. Earnings Estimates and Stock Price Movement - The Zacks rating system is based on the consensus measure of EPS estimates from sell-side analysts, reflecting the company's changing earnings picture [1][2]. - Changes in earnings estimates are strongly correlated with near-term stock price movements, particularly due to the actions of institutional investors who adjust their valuations based on these estimates [4]. OCADO GROUP's Earnings Outlook - The recent upgrade for OCADO GROUP signifies an improvement in its underlying business, which is expected to lead to increased stock prices as investors respond positively to this trend [5][10]. - Analysts have raised their earnings estimates for OCADO GROUP, with the Zacks Consensus Estimate increasing by 1.6% over the past three months [8]. Zacks Rank System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with a strong historical performance, particularly for Zacks Rank 1 stocks which have averaged a +25% annual return since 1988 [7]. - OCADO GROUP's upgrade to Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, indicating a strong potential for market-beating returns in the near term [10].

Core Viewpoint - The Beachbody Company, Inc. (BODI) has shown significant stock price appreciation of 82.1% over the past four weeks, with a mean price target of $11.5 suggesting a further upside potential of 30.2% [1] Price Targets and Estimates - The mean estimate consists of four short-term price targets with a standard deviation of $4.45, indicating variability among analysts. The lowest estimate is $6.50 (26.4% decline), while the highest is $15.50 (75.5% increase) [2] - Analysts' price targets can often mislead investors, as empirical research shows that they rarely indicate actual stock price movements [7][10] - A low standard deviation in price targets suggests a high degree of agreement among analysts regarding the stock's price direction, which can serve as a starting point for further research [9] Earnings Estimates and Analyst Sentiment - There is growing optimism among analysts regarding BODI's earnings prospects, supported by a strong consensus in revising EPS estimates higher, which correlates with potential stock price increases [11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 64.9%, with two estimates moving higher and no negative revisions [12] - BODI holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating strong potential for near-term upside [13] Conclusion on Price Movement - While the consensus price target may not be a reliable measure of BODI's potential gains, the implied direction of price movement appears to be a useful guide for investors [14]

Market Overview - The U.S. market experienced a strong rebound during the holiday-shortened trading week, with major indexes like the Nasdaq Composite, S&P 500, and Dow Jones Industrial Average gaining 2.16%, 2.15%, and 2.73% respectively [1] - The rally was supported by increasing investor confidence in a potential interest rate cut by the Federal Reserve in December, fueled by recent economic data and dovish comments from Fed officials [1] Retail Sales and Economic Indicators - Retail sales rose by 0.2% in September, following a 0.6% gain in August, with a year-over-year increase of 4.3% [2] - The Producer Price Index increased by 0.3% in September, maintaining a year-over-year growth of 2.7%, which is above the Fed's 2% target [2] - The consumer confidence index fell to a seven-month low of 88.7 in November, below the consensus estimate of 93.5, indicating concerns about affordability amid a sluggish labor market and high unemployment rate [2] Zacks Recommendations and Performance - MBX Biosciences, Inc. saw a 97.1% increase since its upgrade to Zacks Rank 2 (Buy) on October 1, significantly outperforming the S&P 500's 2.6% increase [3][6] - AXIS Capital Holdings Limited returned 8.5% since its upgrade to Zacks Rank 2 on October 2, also outperforming the S&P 500 [4] - A hypothetical portfolio of Zacks Rank 1 (Strong Buy) stocks returned +20.65% in 2023, compared to +24.83% for the S&P 500 index [5] Focus List and Model Portfolios - The Zacks Focus List portfolio returned +18.3% in 2025 (through September 30) compared to +14.8% for the S&P 500 index [11] - CACI International Inc. gained 28.6% over the past 12 weeks, while Quanta Services, Inc. returned 23% in the same period, both outperforming the S&P 500's 6% increase [10] - The Zacks Earnings Certain Admiral Portfolio (ECAP) returned -1.30% in Q3 2025, underperforming the S&P 500 index's +8.1% gain [16] Dividend Portfolio Performance - Johnson & Johnson returned 16.8% over the past 12 weeks, while UnitedHealth Group Incorporated increased by 6.4%, benefiting from investor interest in quality dividend stocks amid market volatility [19] - The Zacks Earnings Certain Dividend Portfolio (ECDP) returned -0.01% in Q3 2025, compared to the S&P 500 index's +8.1% gain [21] Top 10 Stocks Performance - Coherent Corp. from the Zacks Top 10 Stocks for 2025 jumped 73.4% year-to-date, outperforming the S&P 500 index's 16.7% increase [23] - The Top 10 portfolio returned +62.98% in 2024, significantly outperforming the S&P 500 index's +25.04% [24] - Since 2012, the Top 10 portfolio has produced a cumulative return of +2,553.1%, compared to +545.2% for the S&P 500 index [25]

Core Viewpoint - C3.ai, Inc. is facing significant challenges with expected earnings and revenue declines, which may impact investor sentiment and stock performance in the near term [2][3]. Company Performance - C3.ai, Inc. closed at $14.45, reflecting a +2.05% increase from the previous day, outperforming the S&P 500's gain of 0.54% [1] - The stock has decreased by 16.85% over the past month, underperforming the Computer and Technology sector's loss of 1.42% and the S&P 500's loss of 0.8% [1]. Earnings Expectations - The company is expected to report earnings of -$0.32 per share on December 3, 2025, indicating a year-over-year decline of 433.33% [2]. - For the entire year, the Zacks Consensus Estimates forecast earnings of -$1.33 per share and revenue of $299.06 million, representing declines of -224.39% and -23.13%, respectively, compared to the previous year [3]. Analyst Sentiment - Recent changes to analyst estimates for C3.ai, Inc. reflect shifting business dynamics, with positive revisions indicating analyst optimism about future profitability [3]. - The Zacks Rank system, which incorporates estimate changes, currently assigns C3.ai, Inc. a rank of 3 (Hold), with the consensus EPS estimate remaining stagnant over the past month [5]. Industry Context - C3.ai, Inc. operates within the Computers - IT Services industry, which ranks in the top 39% of all industries according to the Zacks Industry Rank [6]. - The strength of individual industry groups is measured by the Zacks Industry Rank, with top-rated industries outperforming lower-rated ones by a factor of 2 to 1 [6].

Core Viewpoint - Commercial Metals (CMC) shows a significant improvement in earnings outlook, making it an attractive investment option as analysts continue to raise earnings estimates for the company [1][2]. Earnings Estimates - Analysts' optimism regarding the earnings prospects of Commercial Metals is leading to higher estimates, which is expected to positively impact the stock price [2]. - The current quarter's earnings estimate is $1.41 per share, reflecting an increase of +80.8% year-over-year, with a 5.41% rise in the Zacks Consensus Estimate over the last 30 days [6]. - For the full year, the expected earnings are $5.87 per share, indicating a year-over-year change of +87.5%, with two estimates moving up recently and no negative revisions [7]. Zacks Rank - The favorable estimate revisions have resulted in Commercial Metals achieving a Zacks Rank 1 (Strong Buy), which is associated with significant outperformance compared to the S&P 500 [8]. - The Zacks Rank system has a strong track record, with Zacks 1 Ranked stocks averaging an annual return of +25% since 2008 [3]. Stock Performance - Commercial Metals shares have increased by 6.6% over the past four weeks, indicating investor confidence in the company's earnings growth prospects [9].

Core Insights - Zacks Premium provides various tools for investors to enhance their stock market strategies and confidence [1] - The Zacks Style Scores serve as complementary indicators to the Zacks Rank, helping investors identify stocks with high potential for market outperformance [2] Zacks Style Scores Overview - Stocks are rated A, B, C, D, or F based on value, growth, and momentum characteristics, with higher scores indicating better chances of outperforming the market [3] - The Style Scores are categorized into four types: Value Score, Growth Score, Momentum Score, and VGM Score [3][4][5][6] Value Score - The Value Score identifies attractive and discounted stocks using ratios like P/E, PEG, Price/Sales, and Price/Cash Flow [3] Growth Score - The Growth Score focuses on a company's financial strength and future outlook, analyzing projected and historical earnings, sales, and cash flow [4] Momentum Score - The Momentum Score assesses trends in stock prices and earnings outlooks, utilizing factors like one-week price change and monthly earnings estimate changes [5] VGM Score - The VGM Score combines the three Style Scores to identify companies with the best value, growth forecasts, and momentum [6] Zacks Rank Integration - The Zacks Rank is a proprietary model based on earnings estimate revisions, aiding investors in building successful portfolios [7] - Stocks rated 1 (Strong Buy) have produced an average annual return of +23.93% since 1988, significantly outperforming the S&P 500 [8] Stock Selection Strategy - Investors should prioritize stocks with a Zacks Rank of 1 or 2 and Style Scores of A or B for optimal success [9] - Stocks with lower ranks but high Style Scores may still face downward price pressure due to negative earnings forecasts [10] Company Spotlight: Global Payments (GPN) - Global Payments, headquartered in Atlanta, has been in the payment technology services sector since 1967 and has expanded through acquisitions and joint ventures [11] - GPN holds a 3 (Hold) Zacks Rank with a VGM Score of A and a Growth Style Score of B, indicating a year-over-year earnings growth forecast of 5.7% for the current fiscal year [12] - The Zacks Consensus Estimate for GPN's earnings has increased by $0.02 to $12.21 per share, with an average earnings surprise of +1.9% [12][13]

Core Insights - Zacks Premium provides tools for investors to enhance their stock market strategies, including daily updates on Zacks Rank and Industry Rank, research reports, and stock screens [1] - The Zacks Style Scores are designed to help investors select stocks with the highest potential to outperform the market in the short term [2] Zacks Style Scores Overview - Stocks are rated from A to F based on value, growth, and momentum characteristics, with higher scores indicating a better chance of outperforming the market [3] - The Style Scores are categorized into four types: Value Score, Growth Score, Momentum Score, and VGM Score, each focusing on different investment strategies [3][4][5][6] Value Score - The Value Score identifies attractive stocks using financial ratios such as P/E, PEG, Price/Sales, and Price/Cash Flow, targeting undervalued stocks [3] Growth Score - The Growth Score assesses stocks based on projected and historical earnings, sales, and cash flow, aiming to find companies with sustainable growth potential [4] Momentum Score - The Momentum Score focuses on price trends and earnings outlook changes, helping investors identify optimal entry points for stocks [5] VGM Score - The VGM Score combines all three Style Scores, providing a comprehensive indicator for investors who utilize multiple investment strategies [6] Zacks Rank Integration - The Zacks Rank, based on earnings estimate revisions, has shown that 1 (Strong Buy) stocks have an average annual return of +23.93% since 1988, significantly outperforming the S&P 500 [7] - Investors are encouraged to consider stocks with a Zacks Rank of 1 or 2 and Style Scores of A or B for the highest probability of success [9] Company Spotlight: Uber Technologies - Uber Technologies holds a Zacks Rank of 3 (Hold) and a VGM Score of A, making it a potential growth investment [11] - The company is forecasted to achieve year-over-year earnings growth of 11.2% for the current fiscal year, supported by a Growth Style Score of B [11] - Recent analyst revisions have increased Uber's earnings estimate for fiscal 2025 by $2.17 to $5.07 per share, with an average earnings surprise of +242.6% [12]

Core Viewpoint - MediaAlpha, Inc. (MAX) is showing potential for a bullish trend following a breakout above the 50-day moving average, indicating a key level of support [1][2]. Technical Analysis - MAX has moved 10.7% higher over the last four weeks, suggesting a possible rally [2]. - The 50-day simple moving average is a significant indicator for traders, marking the first sign of an up or down trend [2]. Earnings Estimates - Positive earnings estimate revisions support the bullish outlook for MAX, with no estimates decreasing in the past two months and two estimates increasing [3]. - The consensus estimate for MAX has also risen, reinforcing the potential for further gains [3].